Advertisement
Canada markets close in 20 minutes
  • S&P/TSX

    21,773.15
    +64.71 (+0.30%)
     
  • S&P 500

    4,958.20
    -52.92 (-1.06%)
     
  • DOW

    37,923.91
    +148.53 (+0.39%)
     
  • CAD/USD

    0.7272
    +0.0009 (+0.12%)
     
  • CRUDE OIL

    83.21
    +0.48 (+0.58%)
     
  • Bitcoin CAD

    88,359.53
    +1,333.06 (+1.53%)
     
  • CMC Crypto 200

    1,383.97
    +71.35 (+5.44%)
     
  • GOLD FUTURES

    2,409.30
    +11.30 (+0.47%)
     
  • RUSSELL 2000

    1,938.86
    -4.10 (-0.21%)
     
  • 10-Yr Bond

    4.6150
    -0.0320 (-0.69%)
     
  • NASDAQ

    15,247.35
    -354.15 (-2.27%)
     
  • VOLATILITY

    18.99
    +0.99 (+5.51%)
     
  • FTSE

    7,895.85
    +18.80 (+0.24%)
     
  • NIKKEI 225

    37,068.35
    -1,011.35 (-2.66%)
     
  • CAD/EUR

    0.6825
    +0.0004 (+0.06%)
     

Select Medical Holdings (NYSE:SEM) Has Re-Affirmed Its Dividend Of US$0.13

Select Medical Holdings Corporation (NYSE:SEM) will pay a dividend of US$0.13 on the 1st of June. This means the annual payment is 2.1% of the current stock price, which is above the average for the industry.

See our latest analysis for Select Medical Holdings

Select Medical Holdings' Dividend Is Well Covered By Earnings

Impressive dividend yields are good, but this doesn't matter much if the payments can't be sustained. Prior to this announcement, Select Medical Holdings' earnings easily covered the dividend, but free cash flows were negative. With the company not bringing in any cash, paying out to shareholders is bound to become difficult at some point.

ADVERTISEMENT

Looking forward, earnings per share is forecast to fall by 9.7% over the next year. If the dividend continues along recent trends, we estimate the payout ratio could be 27%, which we consider to be quite comfortable, with most of the company's earnings left over to grow the business in the future.

historic-dividend
historic-dividend

Select Medical Holdings' Dividend Has Lacked Consistency

Looking back, Select Medical Holdings' dividend hasn't been particularly consistent. Due to this, we are a little bit cautious about the dividend consistency over a full economic cycle. Since 2013, the first annual payment was US$0.40, compared to the most recent full-year payment of US$0.50. This implies that the company grew its distributions at a yearly rate of about 2.5% over that duration. We're glad to see the dividend has risen, but with a limited rate of growth and fluctuations in the payments the total shareholder return may be limited.

The Dividend Looks Likely To Grow

Given that the dividend has been cut in the past, we need to check if earnings are growing and if that might lead to stronger dividends in the future. Select Medical Holdings has impressed us by growing EPS at 33% per year over the past five years. A low payout ratio gives the company a lot of flexibility, and growing earnings also make it very easy for it to grow the dividend.

Our Thoughts On Select Medical Holdings' Dividend

Overall, we don't think this company makes a great dividend stock, even though the dividend wasn't cut this year. While Select Medical Holdings is earning enough to cover the payments, the cash flows are lacking. This company is not in the top tier of income providing stocks.

Market movements attest to how highly valued a consistent dividend policy is compared to one which is more unpredictable. Still, investors need to consider a host of other factors, apart from dividend payments, when analysing a company. Case in point: We've spotted 3 warning signs for Select Medical Holdings (of which 1 can't be ignored!) you should know about. Is Select Medical Holdings not quite the opportunity you were looking for? Why not check out our selection of top dividend stocks.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.